Citigroup Lowers Health Catalyst PT to $2.75, Maintains Neutral Rating

Friday, Jan 9, 2026 11:02 am ET1min read
HCAT--

Citigroup Lowers Health Catalyst PT to $2.75, Maintains Neutral Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet